The page is the record's research on the issuer — no analyst, no rating, no view.

# Anixa Biosciences Inc (NASDAQ: ANIX) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is Anixa Biosciences Inc, listed on NASDAQ under the ticker ANIX, with ISIN US03528H1095 and LEI 549300PW2C2QTAJL2D19. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted.

## The disclosure read

The record holds 38 filings in the twelve months to 2026-11-08, on 29 filing days. The median gap between filing days is 4.5 days, against a NASDAQ median of 6.0 days and a 2834 Pharmaceutical Preparations sector median of 6.0 days. The latest filing is dated 2026-11-02 and is of type directors_dealings, 6 days before the record date; the NASDAQ median latency is 5.0 days and the sector median latency is 4.0 days. The filings by type are 28 directors_dealings, 4 results, 2 agm_egm, 2 corporate_news and 2 regulatory_filing.

## Auditor

The auditor of record is HASKELL & WHITE LLP, located in Irvine, California. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.

## Orderability

The outcome is not determinable, as the chapter's orderability section carries no client_categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

The record finds 3 research houses named on the issuer's investor-relations page: Freedom Capital Markets, H.C. Wainwright & Co., and Maxim Group.

## Open research

No openly published research notes are found on the record.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The vintage is sealed. The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.

## Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0000715446.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/ANIX (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/715446/000149315226001845/form10-k.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://ir.anixa.com/stock (coverage)
- https://mcp.us-cm-kg.ai/record/NASDAQ/ANIX (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ANIX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
